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Abstract
Background: This study aimed to determine the prevalence of gonorrhoea and factors associated with rectal
gonorrhoea among men reporting sexual contact with men with gonorrhoea.
Methods: Men who presented to Melbourne Sexual Health Centre reporting sexual contact with a male with
gonorrhoea were prospectively identified between March 2011 and December 2013. These men were screened for
pharyngeal and rectal gonorrhoea using culture. The prevalence of gonorrhoea among contacts was compared to
that among all men who have sex with men (MSM) screened at the clinic over the same period.
Results: Among 363 contacts of gonorrhoea the prevalence of rectal gonorrhoea was 26.4 % (95 % CI: 21.8 %-31.0 %)
compared to 3.9 % (95 % CI: 3.7 %-4.2 %) among clinic attendees (p < 0.001). The prevalence of pharyngeal gonorrhoea
among contacts was 9.4 % (95 % CI: 6.4 %-12.4 %) compared to 2.1 % (95 % CI: 1.9 %-2.4 %) among clinic attendees
(p < 0.001). Among contacts who reported not always using condoms during receptive anal sex with casual partners,
rectal gonorrhoea was cultured in 42.4 % compared with 12.7 % among contacts reporting no receptive anal sex
(p < 0.001) and 20.2 % among those reporting always using condoms (p < 0.001). On multivariate analysis rectal
gonorrhoea was associated with inconsistent condom use during receptive anal sex with casual partners (adjusted
odds ratio (AOR): 4.16; 95 % CI: 1.87-9.26) and a reported past history of gonorrhoea (AOR: 1.77; 95 % CI: 1.01-3.14).
Conclusions: The high proportion of positive cases of gonorrhoea among contacts in this study supports
epidemiological treatment of MSM presenting as contacts of gonorrhoea.
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Background
Gonorrhoea remains one of the most prevalent sexually
transmitted infections (STIs) worldwide [1], with sub-
stantial prevalence reported among men who have sex
with men (MSM) [2]. The reported prevalence of rectal
and pharyngeal gonorrhoea among MSM in selected
studies has ranged from 3.4 % to 6.9 % [3–7] and 3.9 %
to 9.2 % [3–7] respectively. Urethral gonorrhoea typically
manifests with purulent urethral discharge while rectal and
pharyngeal infections are usually asymptomatic. Rectal
gonorrhoea is believed to increase the risk of HIV trans-
mission between men [8]. The continued transmission of
gonorrhoea is of public health concern due to increasing
antimicrobial resistance to various classes of antibiotics in-
cluding extended spectrum cephalosporins [9–12].
The public health control of gonorrhoea in MSM has to
a large extent hinged on screening and treatment: current
guidelines recommend screening MSM for gonorrhoea at
least annually with more frequent screening for higher risk
men [13,14]. The Australian STI testing guidelines suggest
that all MSM be screened for rectal and pharyngeal gonor-
rhoea, while testing for urethral gonorrhoea is reserved
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only for men with urethral symptoms [13–15]. Chlamydial
screening from the rectum and urethra are also recom-
mended as part of the screening process [13,14]. A number
of clinical guidelines recommend that individuals present-
ing as sexual contacts of partners diagnosed with gonor-
rhoea be treated empirically for gonorrhoea at the first
clinic visit [13,16,17]. However, evidence for this policy in
the case of MSM is not available.
This study aimed to provide data on the prevalence of
gonorrhoea among men reporting sex with a man in-
fected with gonorrhoea and factors predictive of gonor-
rhoea infection among such men.
Methods
This study was conducted at the Melbourne Sexual
Health Centre, the main public sexually health clinic in
Melbourne, Victoria, Australia. In order to prospectively
identify patients presenting as sexual contacts of individ-
uals with gonorrhoea, all patients reporting contact with
gonorrhoea were systematically recorded in the elec-
tronic medical record from March 2011. Such patients
were identified by the clinic’s triage nurse so that epi-
demiological treatment for gonorrhoea could be offered
in all cases. These men will henceforth be referred to as
“contacts” of gonorrhoea. Clinical data including sexual
histories routinely obtained by computer assisted self-
interview (CASI) and the result of laboratory investiga-
tions were obtained on all MSM reporting contact with
gonorrhoea from March 2011 to December 2013.
Men were considered MSM if they reported a male
sex partner within the last year. MSM were routinely
asked a series of pre-specified questions regarding their
recent sexual behaviours using CASI, including whether
they had a regular or casual sexual partners together
with questions on condom use for insertive and recep-
tive anal sex. The CASI did not ask about oral sex.
MSM were not required to undertake CASI if they had
completed it at a previous visit within 3 months. Those
who did not undertake CASI were excluded from the
study. Also excluded were men who presented to the
clinic because they had sexual contact with a gonorrhoea
infected male more than once within 4 weeks. These
men were excluded as clinic policy was to undertake a
test of cure one week after treatment for gonorrhoea.
All asymptomatic MSM attending the clinic were rou-
tinely screened for gonorrhoea with a pharyngeal and an
anal swab for culture using modified Thayer-Martin
medium, as nucleic acid amplification testing for gonor-
rhoea was not used at the centre over the study dur-
ation. Inoculated culture plates were immediately taken
to the clinic’s onsite laboratory and intubated at 36° in
5 % carbon dioxide for 48 h. Presumptive N. gonorrhoeae
colonies were selected and a Gram stain smear prepared.
Further testing using oxidase and carbohydrate reactions
aided in speciation. Urethral swabs for gonorrhoea cul-
ture were only obtained in men who presented with ur-
ethral discharge. In addition urine and an anal swab
were obtained for chlamydia screening using strand dis-
placement amplification.
The prevalence of contacts in the study who tested
positive for pharyngeal, rectal and urethral gonorrhoea
was determined. These data were compared with the
background prevalence of gonorrhoea among all MSM
who attended the clinic over the same time period. Be-
havioural factors potentially associated with gonorrhoea
infection among contacts of gonorrhoea were explored
using the Chi-square test for categorical variables. Those
variables with a p-value <0.1 were entered into a logistic
regression model using SPSS version 21. Ethical approval
for this study was granted by the Alfred Hospital Re-
search Ethics Committee (300/13).
Results
Over the study period there were 363 clinic visits by 346
contacts presenting to the clinic reporting sexual contact
with a man with gonorrhoea and who undertook CASI.
This included 13 contacts who presented twice and 2
who presented on three occasions at least 4 weeks apart.
There were 38 MSM who presented as contacts but
were excluded because they did not undertake CASI.
During the 363 clinical presentations by contacts, there
were 362 pharyngeal swabs, 352 anal swabs and 59 ureth-
ral swabs obtained for gonorrhoea culture. Over the same
period there were 20,377 clinic visits by 9,108 MSM dur-
ing which 19,793 pharyngeal, 18,117 anal, and 2,251 ureth-
ral swabs were obtained for gonorrhoea culture.
Among the 363 contacts of gonorrhoea, 107 (29.5 %,
95 % confidence interval (CI): 24.8 %-34.2 %) had gonor-
rhoea isolated at the pharynx (n = 34), rectum (n = 93) or
urethra (n = 5). Concurrent infection of the pharynx and
rectum occurred in 6 % of contacts. Gonorrhoea was
isolated in the urethra and pharynx in one contact, and
in the urethra and rectum in two contacts. Of the 15
contacts who had repeat visits, only one had gonorrhoea
isolated on both occasions.
Rectal gonorrhoea was isolated in 26.4 % (95 % CI:
21.8 %-31.0 %) of contacts, several fold higher than that
among all clinic MSM attendees over the same period:
3.9 % (95 % CI: 3.7 %-4.2 %; p < 0.001). Pharyngeal gon-
orrhoea was isolated in 9.4 % (95 % CI: 6.4 %-12.4 %) of
contacts, significantly higher than the 2.1 % (95 % CI:
1.9 %-2.4 %; p < 0.001) seen in all clinic MSM attendees
over the same time. The prevalence of rectal chlamydia
among contacts of gonorrhoea was also significantly
higher than among clinic MSM attendees (12.3 % vs
6.4 %; p < 0.001). Urethral gonorrhoea was isolated in
8.5 % (8/59; 95 % CI: 0.8 %-16.2 %) of contacts tested
for urethral gonorrhoea compared to 24.3 % (547/2251;
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95 % CI: 22.5 %-26.1 %) among all MSM attendees
tested for urethral gonorrhoea over the same period.
The median age among contacts was 28 years (range:
16–60). The sexual relationships and behaviours re-
ported by contacts overall are summarised in Table 1.
Among contacts who reported engaging in anal sex,
nearly half had casual sex partners only while a fifth had
a regular male partner only. The remaining contacts had
a regular partner as well as casual sex partners. Over
three quarters of contacts with a regular sexual partner
did not use condoms all the time during anal sex with
their regular partner. Around half of contacts did not use
condoms all the time with casual sex partners (Table 1).
Factors associated with rectal gonorrhoea infection
among men reporting sex with gonorrhoea infected men
are shown in Table 2. In univariate analysis the factors
associated with rectal gonorrhoea were: sex overseas;
not always using condoms during receptive anal sex with
casual male partners; drug use associated with unpro-
tected anal sex; and having unprotected anal sex with a
partner whose HIV status was unknown. In multi-
variate analysis rectal gonorrhoea was significantly
associated with not always using condom use during
receptive anal sex with casual partners (adjusted odds
ratio (AOR): 4.16; 95 % CI: 1.87-9.26) and a self-
reported past history of gonorrhoea (AOR: 1.77;
95 % CI: 1.01-3.14).
Among 118 contacts who reported not always using con-
doms during receptive anal sex with casual partners (112
men reporting sometimes using condoms and 6 men
reporting never using condoms) the prevalence of rectal
gonorrhoea was 42.4 % (95 % CI: 33.4 %-51.4 %). This was
significantly higher than the 12.7 % seen among con-
tacts who reported no receptive anal sex with casual
partners (p < 0.001). Among contacts diagnosed with
rectal gonorrhoea 15.1 % reported always using con-
doms for receptive anal sex while 4.3 % reported no re-
ceptive anal sex.
Discussion
In this study of men presenting to a sexual health service
reporting sexual contact with a man with gonorrhoea,
overall 26.4 % were diagnosed with rectal gonorrhoea by
culture. Among the subset of contacts of gonorrhoea
who reported either inconsistent or no condom use for
receptive anal sex with casual partners, the prevalence of
rectal gonorrhoea was higher – 42 %. These data lend
empirical support to the recommended practice of pro-
viding epidemiological treatment of individuals reporting
sexual contact with gonorrhoea, in this case, where the
patient and partner are MSM.
As culture has poor sensitivity for detecting gonorrhoea
at extragenital sites the true prevalence of pharyngeal and
rectal gonorrhoea among men in this study will have been
higher than the rates reported here. The sensitivity of
culture for the detection of pharyngeal gonorrhoea
compared with nucleic acid amplification testing
(NAAT) in four studies of MSM was 47 % [18], 40 %
[3], 39 % [19] and 60 % [20]. In the same four studies
the sensitivity of culture for rectal gonorrhoea com-
pared to NAAT was 56 % [18], 53 % [3], 86 % [19]
and 50 % [20], respectively.
When interpreting these data it should be noted that
we do not know if reported partners actually had
Table 1 Sexual relationships and behaviours reported by men reporting sexual contact with men with gonorrhoea
Sexual relationships and behaviours n (%)
Sexual relationships
No. of men who reported insertive and/or receptive anal sex with a male partner 325
Men who had regular and casual male sex partnersa 100 (30.7 %)
Men who had a regular sex partner only 71 (21.8 %)
Men who had casual sex partners only 154 (47.4 %)
Condom use with regular sex partners
No. of men who reported insertive anal sex with a regular sex partner 151
Men who reported not always using condoms during insertive anal sex with a regular partner 118 (78.1 %)
No. of men who reported receptive anal sex with a regular sex partner 159
Men who reported not always using condoms during receptive anal sex with a regular partner 124 (78.0 %)
Condom use with casual sex partnersa
No. of men who reported insertive anal sex with a casual sex partner 225
Men who reported not always using condoms during insertive anal sex with casual partners 116 (51.6 %)
No of men who reported receptive anal sex with a casual sex partner 227
Men who reported not always using condoms during receptive anal sex with casual partners 119 (52.4 %)
aRelationships and condom use over prior 3 months
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gonorrhoea, and if they did, their site of infection. Nor
do we know if contacts in the study were infected by or
transmitted infection to their partner. Given most con-
tacts in this study had pharyngeal or rectal infection, it
is possible urethral gonorrhoea was common among
partners. This would fit with the observed protective ef-
fect of condoms during receptive anal sex against rectal
gonorrhoea. Because the data were not collected we are
unable to comment on the influence of oral sex on the
prevalence of pharyngeal gonorrhoea among contacts.
As data on the actual number of sexual acts with in-
fected partners was not available, per act transmission
probabilities could not be calculated; however, they are
consistent with a relatively high rate of gonorrhoea













≥28 43 (22.9) 145 (77.1) 188 1
<28 50 (30.5) 114 (69.5) 164 1.48 (0.92 - 2.63) 0.107
Sex overseas in the past 12 months
No 52 (22.1) 183 (77.9) 235 1 1
Yes 32 (33.3) 64 (66.7) 96 1.76 (1.04 – 2.97) 0.035 1.77 (0.98 – 3.18) 0.057
Number of male sex partners in
past 3 months
0-2 29 (20.9) 110 (79.1) 139 1 1
≥3 63 (30.1) 146 (69.9) 209 1.62 (0.99 – 2.68) 0.056 0.96 (0.49 – 1.89) 0.913
Condom use with regular sex
partner during receptive anal sex
No receptive anal sex 134 (74.0) 47 (26.0) 181 1
Always used condoms 7 (21.2) 26 (78.8) 33 0.77 (0.31 – 1.89) 0.564
Did not always use condomsb 34 (27.9) 88 (72.1) 122 1.10 (0.66 – 1.85) 0.714
Condom use with casual sex
partner during receptive anal sex
in past 3 months
No receptive sex 13 (12.7) 89 (87.3) 102 1 1
Always used condoms 21 (20.2) 83 (79.8) 104 1.73 (0.82 – 3.68) 0.153 1.50 (0.65 – 3.44) 0.339
Did not always use condomsc 50 (42.4) 68 (57.6) 118 5.03 (2.53 – 10.01) <0.001 4.16 (1.87 – 9.26) <0.001
HIV status
HIV negative or unknown 88 (27.1) 237 (72.9) 325 1
HIV positive 5 (18.5) 22 (81.5) 27 0.62 (0.26 – 1.67) 0.337
Past history of gonorrhoea
No 50 (22.8) 169 (77.2) 219 1 1
Yes 40 (32.3) 84 (67.7) 124 1.61 (0.99 – 2.63) 0.058 1.77 (1.01 – 3.10) 0.048
Drug use with unprotected anal
sex in the past 12 monthsa
No 26 (27.4) 69 (72.6) 95 1
Yes 27 (44.3) 34 (55.7) 61 2.11 (1.07 – 4.15) 0.031
Unprotected anal sex with a
partner of unknown HIV status
in the past 12 monthsa
No 24 (25.8) 69 (74.2) 93 1
Yes 30 (44.8) 37 (55.2) 67 2.33 (1.19 – 4.55) 0.013
aCASI only asked these questions if men were HIV negative and if they reported unprotected anal sex for either insertive or receptive anal sex with casual or
regular partners. Because these were only reported by a small proportion of men these were not included in the multivariate analysis
bThis included 65 men who reported never using condoms for receptive anal sex and 57 reporting sometimes using condoms for receptive anal sex
cThis included 6 men who reported never using condoms for receptive anal sex and 113 reporting sometimes using condoms for receptive anal sex
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transmission via anal sex. It remains uncertain whether
sex acts other than oral and anal sex are important in
the transmission of gonorrhoea between men. Although
activities such as fingering and rimming have been pro-
posed [21], firm evidence for these practices remain elu-
sive. That some of the contacts in this study had verified
rectal gonorrhoea in the absence of reported receptive
anal sex or with reported consistent condom use might
suggest alternative modes of acquisition though, alterna-
tively, they may simply reflect inaccurate reporting [22].
Conclusions
Justification for epidemiological treatment for a curable
sexually transmitted infection, that is, treatment of a
contact prior to the availability of test results depends
on the rate of infection among such contacts, the level
of side effects, and the extent to which infected contacts
default from treatment because of loss to follow up. The
high proportion of positive cases of gonorrhoea among
contacts in this study, particularly among those engaging
in unprotected receptive anal sex, supports the need for
epidemiological treatment for men reporting sexual con-
tact with males with gonorrhoea. Most guidelines cur-
rently recommend treating uncomplicated gonorrhoea
with a combination of single dose azithromycin and cef-
triaxone where in non-allergic patients serious adverse
events are rare. Furthermore the study findings empha-
sise that promotion of condom use for receptive anal sex
remains at the cornerstone of reducing transmission of
rectal gonorrhoea.
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